(Q53149178)

11 May 2018

title

Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease. (English)

1 reference

11 May 2018

4

Taner Basturk

1 reference

11 May 2018

Tamer Sakaci

5

Tamer Sakaci

1 reference

11 May 2018

Yener Koc

3

Yener Koc

1 reference

11 May 2018

Elbis Ahbap

6

Elbis Ahbap

1 reference

11 May 2018

Abdulkadir Unsal

1

Abdulkadir Unsal

1 reference

11 May 2018

Ayse Sinangil

7

Ayse Sinangil

1 reference

11 May 2018

Sennur Kose Budak

2

Sennur Kose Budak

1 reference

11 May 2018

publication date

6 August 2012

1 reference

11 May 2018

Kidney and Blood Pressure Research

published in

1 reference

11 May 2018

volume

36

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

55-64

1 reference

11 May 2018

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

cites work

1 reference

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients

21 January 2018

1 reference

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients

21 January 2018

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

Fibroblast growth factor 23: roles in health and disease

21 January 2018

1 reference

Does FGF23 toxicity influence the outcome of chronic kidney disease?

21 January 2018

1 reference

New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter.

21 January 2018

1 reference

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

21 January 2018

1 reference

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

FGF-23 is elevated by chronic hyperphosphatemia

21 January 2018

1 reference

Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

21 January 2018

1 reference

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?

21 January 2018

1 reference

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.

21 January 2018

1 reference

Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.

21 January 2018

1 reference

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production

21 January 2018

1 reference

The role of vitamin D in left ventricular hypertrophy and cardiac function

21 January 2018

1 reference

Vitamin D and the cardiovascular system

21 January 2018

1 reference

Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease

21 January 2018

1 reference

FGF-23 in dialysis patients: ready for prime time?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000339026

1 reference

11 May 2018

1 reference

11 May 2018